Varigen™ Biosciences, Natural Products by Design™ is an NIH- and NSF-funded effort to harness naturally occurring microbial diversity to develop the next generation of natural product drugs through genomics and metagenomics.
BioForward recently welcomed Mohammed Soumaoro aboard as its membership experience and program coordinator. Soumaoro will support BioForward’s membership activities through improving membership experience and communications, supporting the purchasing consortium administration, internal project management, assisting with member events, and providing executive support to the CEO. “We are thrilled that Mohammed has joined our BioForward team,” CEO […]
This week, Promega Corporation announced the opening of the Kornberg Center, a new three-story 280,000-square-foot (over 85,000 square meters) research and development facility at its Fitchburg campus. Kornberg Center will support core product and technology development in life science research, cellular and molecular biology, genetic identity, clinical diagnostic and scientific applications, and training.
Located in the University of Wisconsin Research Park in Madison, Wisconsin, Object Pharma is developing new therapeutic drugs treating muscle hyperactivity. We also manufacture and sell all seven serotypes of botulinum toxin for use by accredited researchers worldwide.
At Gilson, we help life scientists at the bench achieve more productive research and verifiable data. And during the pandemic, we’ve helped support critical testing workflows and other COVID-related initiatives.
BioForward Wisconsin, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster representing more than 220 member organizations, is thrilled to announce the election of three new board members, effective January 1, 2021. Wisconsin has a uniquely diverse wealth of sectors that make up the Wisconsin biohealth region. BioForward serves all these sectors including research […]
By Janet WhiteBioForward Board MemberDirector of Strategic Portfolio Management, Promega With the rollercoaster of a year we’ve all experienced, the recently released Wisconsin Biohealth: Industry Landscape and Economic Impact Report has been a welcome bright spot highlighting the amazing successes of our region’s biohealth companies and organizations. Simply put, the biohealth industry is a leading […]
On April 16, 2020, Wisconsin Secretary-designee of the Department of Health Services, Andrea Palm, issued Emergency Order #28 at the direction of Governor Tony Evers. This new Order extends Wisconsin’s “Safer at Home” Order until 8:00 a.m. on May 26, 2020, or until a superseding order is issued, and modifies the original order. The original Safer at Home Order issued on March 25, Emergency Order #12, remains in effect until April 24, 2020.
BioForward is actively engaged with community partners, elected officials, state agencies and industry partners to meet the challenges of combating the coronavirus and demonstrating that Wisconsin can help lead the nation through this healthcare crisis. PPE Focus Eight Madison-area community providers serving people with developmental disabilities and seniors received much-needed PPE as they battle the […]
Milwaukee Journal Sentinel: The Medical College of Wisconsin Affiliated Hospitals, a consortium of 11 hospitals and institutions that oversees residency and fellowship programs for medical school graduates who are completing their training, has received national recognition for creating a respectful, supportive environment for medical education and patient care. The consortium is one of the three […]
Somerset, N.J., – March 7, 2016 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Eric Valentine, Global Director, Clinical Distribution Services, will present at the upcoming Clinical Trial Supply New England Conference, to be […]
Wisconsin State Journal: NeuWave Medical, a Madison medical device company, is being bought by Ethicon, part of the Johnson & Johnsonconglomerate. Terms of the transaction have not been disclosed. No jobs in Madison are expected to be lost. “We are really excited to be acquired by a great company like Johnson & Johnson,” NeuWave CEO […]
Milwaukee Journal Sentinel: Madison-based BioForward, a trade organization for Wisconsin’s bioscience industry, is opening an office at theUWM Innovation Campus in Wauwatosa. BioForward has hired Michael Harrison, a former Medical College of Wisconsin researcher and co-founder ofAngio360 Diagnostics, to run the office, said Lisa Johnson, chief executive officer. “We can’t only be about Madison,” Johnson […]
Milwaukee Journal Sentinel: County Line Pharmaceuticals, a Brookfield company founded in 2007, has agreed to be bought by Alvogen, a privately owned pharmaceutical company, reportedly for $300 million. County Line, which did not return calls for comment Tuesday, sells so-called specialty generic pharmaceuticals — older drugs with a limited market and typically high prices. Its […]
Via Xconomy —Arrowhead Research, whose research and development operations are headquartered in Madison, said a therapeutic it’s developing could potentially prevent blood clots and treat angioedema, a condition marked by the swelling of blood vessels. Arrowhead (NASDAQ:ARWR) recently presented animal study data at the American Academy of Allergy, Asthma & Immunology Annual Meeting. The company’s stock price […]